SIGN UP
LOG IN
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·04/07/2025 17:05:50
Listen to the news
Gainers
- Bluejay Diagnostics (NASDAQ:BJDX) shares rose 126.3% to $7.99 during Monday's regular session. The company's market cap stands at $4.4 million.
- Artiva Biotherapeutics (NASDAQ:ARTV) shares moved upwards by 35.04% to $3.29. The market value of their outstanding shares is at $80.2 million.
- Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 34.43% to $0.52. The company's market cap stands at $3.2 million.
- Shattuck Labs (NASDAQ:STTK) shares increased by 32.3% to $0.97. The company's market cap stands at $46.4 million.
- Agape ATP (NASDAQ:ATPC) stock rose 30.32% to $1.59. The market value of their outstanding shares is at $6.3 million.
- Sutro Biopharma (NASDAQ:STRO) stock moved upwards by 28.13% to $0.69. The company's market cap stands at $58.1 million.
Losers
- iBio (NASDAQ:IBIO) shares fell 43.0% to $1.84 during Monday's regular session. The market value of their outstanding shares is at $18.1 million.
- China Pharma Holding (AMEX:CPHI) stock decreased by 39.91% to $0.13. The market value of their outstanding shares is at $2.5 million.
- Lexeo Therapeutics (NASDAQ:LXEO) stock fell 29.32% to $1.65. The company's market cap stands at $54.7 million.
- Alumis (NASDAQ:ALMS) stock decreased by 23.49% to $7.69. The company's market cap stands at $418.3 million.
- Aditxt (NASDAQ:ADTX) stock fell 23.16% to $3.63. The market value of their outstanding shares is at $3.7 million.
- Sharps Technology (NASDAQ:STSS) shares decreased by 22.87% to $0.02. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.